Relationship of a dominant advanced glycation end product, serum carboxymethyl-lysine, and abnormal glucose metabolism in adults: The baltimore longitudinal study of aging

No abstract is available for this paper.

• Publication year

  2010

• Venue

  The Journal of Nutrition, Health & Aging

• Publication date

  2010-05-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/S12603-010-0105-YPMID 20818463PMCID PMC3435097
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma Carboxymethyl‐Lysine, an Advanced Glycation End Product, and All‐Cause and Cardiovascular Disease Mortality in Older Community‐Dwelling Adults

  2009cited by this paper
• Carboxymethyl-lysine, an advanced glycation end product, and decline of renal function in older community-dwelling adults

  2009cited by this paper
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National

  2009cited by this paper
• Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus.

  2007cited by this paper
• Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging.

  2007cited by this paper
• Glycotoxins in the diet promote diabetes and diabetic complications

  2007cited by this paper
• The Advanced Glycation End Product Nε-Carboxymethyllysine Is Not a Predictor of Cardiovascular Events and Renal Outcomes in Patients With Type 2 Diabetic Kidney Disease and Hypertension

  2006cited by this paper
• The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.

  2006cited by this paper
• Clinical implications of Nε‐(carboxymethyl)lysine, advanced glycation end product, in children and adolescents with type 1 diabetes

  2005cited by this paper
• Advanced glycation end products and the kidney.

  2005cited by this paper
• Two immunochemical assays to measure advanced glycation end-products in serum from dialysis patients

  2005cited by this paper
• Relationship between blood levels of N-carboxymethyl-lysine and pentosidine and the severity of microangiopathy in type 2 diabetes.

  2004cited by this paper
• Increased accumulation of the glycoxidation product Nepsilon-(carboxymethyl)lysine in hearts of diabetic patients: generation and characterisation of a monoclonal anti-CML antibody.

  2004cited by this paper
• Advanced glycoxidation end products in commonly consumed foods.

  2004cited by this paper
• Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.

  2004cited by this paper
• Time course of specific AGEs during optimised glycaemic control in type 2 diabetes.

  2004cited by this paper
• Elevated serum levels of Nε-carboxymethyl-lysine, an advanced glycation end product, are associated with proliferative diabetic retinopathy and macular oedema

  2004influential reference
• Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes.

  2003cited by this paper
• Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients.

  2003cited by this paper
• Serum levels of low molecular weight advanced glycation end products in diabetic subjects

  2003cited by this paper
• Follow-up report on the diagnosis of diabetes mellitus.

  2003cited by this paper
• Endothelial dysfunction and advanced glycation end products in type 2 diabetes mellitus

  2002cited by this paper
• Advanced glycation end products and endothelial dysfunction in type 2 diabetes.

  2002cited by this paper
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2002cited by this paper
• The worldwide obesity epidemic.

  2001cited by this paper
• Report of the expert committee on the diagnosis and classification of diabetes mellitus.

  1999cited by this paper
• Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease.

  1999cited by this paper
• A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

  1999cited by this paper
• Increased serum levels of advanced glycation end-products and diabetic complications.

  1998cited by this paper
• The advanced glycation end product Nepsilon-(carboxymethyl)lysine is increased in serum from children and adolescents with type 1 diabetes.

  1998cited by this paper
• Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy.

  1997cited by this paper
• N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins.

  1995cited by this paper
• Normal Human Aging: The Baltimore Longitudinal Study of Aging

  1986cited by this paper
• Normal Human Aging: The Baltimore Longitudinal Study on Aging

  1984cited by this paper
• Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol.

  1982cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper

• Association between advanced glycation end products and estimated glomerular filtration rate: a cross-sectional analysis

  2025cites this paper
• Neuropathological links between T2DM and LOAD: systematic review and meta-analysis.

  2025cites this paper
• Effect of High Glucose and Carboxymethyl-Lysine on Osteocyte Gene Expression

  2025cites this paper
• Association between advanced glycation end products and bone mineral density in Mexican population.

  2025cites this paper
• Association between advanced glycation end products and uveitis/scleritis activity in patients with active immune-mediated ocular inflammatory diseases

  2024cites this paper
• Possible Contribution of Advanced Glycated End Products Level in Motor Dysfunction in The Elderly

  2022cites this paper
• Dietary and Plasma Carboxymethyl Lysine and Tumor Necrosis Factor-α as Mediators of Body Mass Index and Waist Circumference among Women in Indonesia

  2019cites this paper
• Identification of Differential Patterns of Oxidative Biomarkers in Prostate Cancer Progression.

  2019cites this paper
• Serum AGEs in black South African patients with type 2 diabetes

  2016cites this paper
• Serum carboxymethyl-lysine, a dominant advanced glycation end product, is increased in women with gestational diabetes mellitus.

  2015cites this paper
• Dietary glycotoxins induce RAGE and VEGF up-regulation in the retina of normal rats.

  2015cites this paper
• Determinants of concentrations of N(ε)-carboxymethyl-lysine and soluble receptor for advanced glycation end products and their associations with risk of pancreatic cancer.

  2014cites this paper
• Total plasma Nε-(carboxymethyl)lysine and sRAGE levels are inversely associated with a number of metabolic syndrome risk factors in non-diabetic young-to-middle-aged medication-free subjects

  2014cites this paper
• Serum carboxymethyllysine, an advanced glycation end product, and age-related macular degeneration: the Age, Gene/Environment Susceptibility-Reykjavik Study.

  2014cites this paper
• Advanced Glycation End Products Acutely Impair Ca2+ Signaling in Bovine Aortic Endothelial Cells

  2013cites this paper
• Plasma biomarkers of oxidative and AGE-mediated damage of proteins and glycosaminoglycans during healthy ageing: a possible association with ECM metabolism.

  2012cites this paper
• Dietary intake associated with serum versus urinary carboxymethyl-lysine, a major advanced glycation end product, in adults: the Energetics Study

  2012cites this paper
• Selective divalent copper chelation for the treatment of diabetes mellitus.

  2012cites this paper
• The glycation pathway in type 2 diabetes and cardiovascular disease

  2012cites this paper
• Tolerancia a la glucosa en personas mayores de 60 años

  2011cites this paper
• Therapeutic Potential of Copper Chelation with Triethylenetetramine in Managing Diabetes Mellitus and Alzheimer’s Disease

  2011cites this paper